States Fund Ibogaine TBI Trials

A Los Angeles Times report says athletes are trying ibogaine for traumatic brain injury while states move to study it. Texas approved $50 million for ibogaine drug‑development trials, Arizona added $5 million for a clinical study, and California is pushing fast‑track research as a Stanford team reported dramatic PTSD/depression/anxiety reductions in special forces veterans. Ibogaine remains Schedule 1 federally, but lawmakers are exploring supervised‑therapy carve‑outs akin to Oregon’s psilocybin model. — This indicates a state‑led pivot toward psychedelic therapeutics that pressures federal scheduling and could redefine brain‑injury and PTSD treatment policy.